ImmunityBio, Inc.

IBRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$113.3M

▲ 668.3% YoY

Net Income

-$351.4M

▲ 15.0% YoY

EPS

$-0.38

▲ 38.7% YoY

Cash

$88.3M

▼ 38.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.